|
⚲
|
| Neogenix Oncology Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001341293 |
| Sale | |
| Fund | |
| Phone | 5164821200 |
| Address | 445 Northern Boulevard Great Neck, 11021 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Phillip Arlen | |
| Philip Arlen | |
| Thomas Lytle | |
| Peter Gordon | |
| Myron Arlen | |
| Timothy Shriver | |
| David Moskowitz | |
| Rishab Gupta | |
| William Ashton |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
MVA Investors, LLC
✚
|
0.0 | |
|
Accolade Blockchain Access Fund II Feeder, L.P.
✚
|
0.0 | |
|
Accolade Blockchain Access Fund II, L.P.
✚
|
0.0 | |
|
Accolade, Inc.
✚
|
0.0 | |
|
Accolade Partners VII-C, L.P.
✚
|
0.0 | |
|
Accordant ODCE Index Fund
✚
|
0.0 | |
|
Accord Catalyst Holdings, L.P.
✚
|
0.0 | |
|
Accord VRH Fund I LP
✚
|
0.0 | |
|
Accountable Healthcare America Inc.
✚
|
0.0 | |
|
Morgan Stanley Capital I Trust 2020-HR8
✚
|
0.0 |